Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4308-4316

  Seow, Vernon ^a   Lim, Junxian ^a   Iyer, Abishek ^a   Suen, Jacky Y ^a   Ariffin, Juliana K ^a   Hohenhaus, Daniel M ^a   Sweet, Matthew J ^a   Fairlie, David P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C5A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL CLEARANCE; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; BUTADIENES; CELLS, CULTURED; COMPLEMENT C5A; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MONOCYTES; NITRILES; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3-KINASES; POLY I-C; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, COMPLEMENT; SALMONELLA TYPHIMURIUM; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTORS;

EID: 84885442197     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301355     Document Type: Article

References (49)

1. Monk, P. N., A. M. Scola, P. Madala, and D. P. Fairlie. 2007. Function, structure and therapeutic potential of complement C5a receptors.Br. J. Pharmacol. 152: 429-448.
2. Gerard, N. P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349: 614-617.
3. Okinaga, S., D. Slattery, A. Humbles, Z. Zsengeller, O. Morteau, M. B. Kinrade, R. M. Brodbeck, J. E. Krause, H. R. Choe, N. P. Gerard, and C. Gerard. 2003. C5L2, a nonsignaling C5A binding protein. Biochemistry 42: 9406-9415.
4. Chen, N. J., C. Mirtsos, D. Suh, Y. C. Lu, W. J. Lin, C. McKerlie, T. Lee, H. Baribault, H. Tian, and W. C. Yeh. 2007. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446: 203-207.
5. Skokowa, J., S. R. Ali, O. Felda, V. Kumar, S. Konrad, N. Shushakova, R. E. Schmidt, R. P. Piekorz, B. Nürnberg, K. Spicher, et al. 2005. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through Gai2 activation that controls C5aR and Fc receptor cooperation. J. Immunol. 174: 3041-3050.
6. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
7. Rossol, M., H. Heine, U. Meusch, D. Quandt, C. Klein, M. J. Sweet, and S. Hauschildt. 2011. LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 31: 379-446.
8. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
9. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
10. Natarajan, M., K. M. Lin, R. C. Hsueh, P. C. Sternweis, and R. Ranganathan. 2006. A global analysis of cross-talk in a mammalian cellular signalling network. Nat. Cell Biol. 8: 571-580.
11. Postma, B., M. J. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. van Strijp, C. J. de Haas, and K. P. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 172: 6994-7001.
12. Wang, M., J. L. Krauss, H. Domon, K. B. Hosur, S. Liang, P.Magotti,M. Triantafilou, K. Triantafilou, J. D. Lambris, and G. Hajishengallis. 2010. Microbial hijacking of complement-Toll-like receptor crosstalk. Sci. Signal. 3: ra11.
13. Hajishengallis, G., and J. D. Lambris. 2010. Crosstalk pathways between Tolllike receptors and the complement system. Trends Immunol. 31: 154-163.
14. Hawlisch, H., Y. Belkaid, R. Baelder, D. Hildeman, C. Gerard, and J. Köhl. 2005. C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22: 415-426.
15. Okazaki, N., K. Hazeki, T. Izumi, K. Nigorikawa, and O. Hazeki. 2011. C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. J. Biochem. 149: 265-274.
16. Bosmann, M., V. R. Patel, N. F. Russkamp, F. Pache, F. S. Zetoune, J. V. Sarma, and P. A. Ward. 2011. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. FASEB J. 25: 4222-4232.
17. Bosmann, M., J. V. Sarma, G. Atefi, F. S. Zetoune, and P. A. Ward. 2012. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB J. 26: 1640-1651.
18. Cavaillon, J. M., C. Fitting, and N. Haeffner-Cavaillon. 1990. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharidestimulated monocytes and macrophages. Eur. J. Immunol. 20: 253-257.
19. Zaal, A., S. N. Lissenberg-Thunnissen, G. van Schijndel, D. Wouters, S. M. van Ham, and A. ten Brinke. 2013. Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production. Immunobiology 218: 175-180.
20. Copeland, S., H. S. Warren, S. F. Lowry, S. E. Calvano, and D. Remick; Inflammation and the Host Response to Injury Investigators. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12: 60-67.
21. Schroder, K., K. M. Irvine, M. S. Taylor, N. J. Bokil, K. A. Le Cao, K. A. Masterman, L. I. Labzin, C. A. Semple, R. Kapetanovic, L. Fairbairn, et al. 2012. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc. Natl. Acad. Sci. USA 109: E944-E953.
22. Ariffin, J. K., and M. J. Sweet. 2013. Differences in the repertoire, regulation and function of Toll-like receptors and inflammasome-forming Nod-like receptors between human and mouse. Curr. Opin. Microbiol. 16: 303-310.
23. Dinakar, C., A. Malur, B. Raychaudhuri, L. T. Buhrow, A. L. Melton, M. S. Kavuru, and M. J. Thomassen. 1999. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann. Allergy Asthma Immunol. 82: 217-222.
24. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1b in monocytes and macrophages. Blood 113: 2324-2335.
25. Finch, A. M., A. K. Wong, N. J. Paczkowski, S. K. Wadi, D. J. Craik, D. P. Fairlie, and S. M. Taylor. 1999. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42: 1965-1974.
26. Reid, R. C., G. Abbenante, S. M. Taylor, and D. P. Fairlie. 2003. A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp- Arg], a potent new antiinflammatory drug. J. Org. Chem. 68: 4464-4471.
27. Trieu, A., N. Bokil, J. A. Dunn, T. L. Roberts, D. Xu, F. Y. Liew, D. A. Hume, K. J. Stacey, and M. J. Sweet. 2009. TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium. Immunol. Cell Biol. 87: 218-225.
28. Bamberg, C. E., C. R. Mackay, H. Lee, D. Zahra, J. Jackson, Y. S. Lim, P. L. Whitfeld, S. Craig, E. Corsini, B. Lu, et al. 2010. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J. Biol. Chem. 285: 7633-7644.
29. Scola, A. M., A. Higginbottom, L. J. Partridge, R. C. Reid, T. Woodruff, S. M. Taylor, D. P. Fairlie, and P. N. Monk. 2007. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J. Biol. Chem. 282: 3664-3671.
30. Lim, J., A. Iyer, J. Y. Suen, V. Seow, R. C. Reid, L. Brown, and D. P. Fairlie. 2013. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27: 822-831.
31. Raby, A. C., B. Holst, J. Davies, C. Colmont, Y. Laumonnier, B. Coles, S. Shah, J. Hall, N. Topley, J. Köhl, et al. 2011. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur. J. Immunol. 41: 2741-2752.
32. Buhl, A. M., N. Avdi, G. S. Worthen, and G. L. Johnson. 1994. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc. Natl. Acad. Sci. USA 91: 9190-9194.
33. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-Activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632.
34. Chanteux, H., A. C. Guisset, C. Pilette, and Y. Sibille. 2007. LPS induces IL-10 production by human alveolar macrophages via MAPKinases-And Sp1-dependent mechanisms. Respir. Res. 8: 71.
35. Liang, S., J. L. Krauss, H. Domon, M. L. McIntosh, K. B. Hosur, H. Qu, F. Li, A. Tzekou, J. D. Lambris, and G. Hajishengallis. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186: 869-877.
36. Wittmann, M., J. Zwirner, V. A. Larsson, K. Kirchhoff, G. Begemann, A. Kapp, O. Götze, and T. Werfel. 1999. C5a suppresses the production of IL-12 by IFNg-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162: 6763-6769.
37. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Köhl, L. Wahl, D. Kuperman, S. Germer, et al. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1: 221-226.
38. Bosmann, M., M. D. Haggadone, M. R. Hemmila, F. S. Zetoune, J. V. Sarma, and P. A. Ward. 2012. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages. J. Immunol. 188: 5086-5093.
39. Bailey, M. J., D. C. Lacey, B. V. de Kok, P. D. Veith, E. C. Reynolds, and J. A. Hamilton. 2011. Extracellular proteomes of M-CSF (CSF-1) and GM-CSFdependent macrophages. Immunol. Cell Biol. 89: 283-293.
40. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252.
41. Lacey, D. C., A. Achuthan, A. J. Fleetwood, H. Dinh, J. Roiniotis, G. M. Scholz, M. W. Chang, S. K. Beckman, A. D. Cook, and J. A. Hamilton. 2012. Defining GM-CSF-And macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188: 5752-5765.
42. la Sala, A., M. Gadina, and B. L. Kelsall. 2005. Gi-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J. Immunol. 175: 2994-2999.
43. Jiang, H., Y. Kuang, Y. Wu, A. Smrcka, M. I. Simon, and D. Wu. 1996. Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. J. Biol. Chem. 271: 13430-13434.
44. Gantke, T., S. Sriskantharajah, M. Sadowski, and S. C. Ley. 2012. IkB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246: 168-182.
45. Rao, K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69: 3-10.
46. Riedemann, N. C., R. F. Guo, T. J. Hollmann, H. Gao, T. A. Neff, J. S. Reuben, C. L. Speyer, J. V. Sarma, R. A. Wetsel, F. S. Zetoune, and P. A. Ward. 2004. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 18: 370-372.
47. Baruah, P., I. E. Dumitriu, T. H. Malik, H. T. Cook, J. Dyson, D. Scott, E. Simpson, and M. Botto. 2009. C1q enhances IFN-g production by antigenspecific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 113: 3485-3493.
48. Seok, J., H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, et al; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110: 3507-3512.
49. Sheridan, C. 2013. Industry pursues co-stimulatory receptor immunomodulators to treat cancer. Nat. Biotechnol. 31: 181-183.